| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:1795.)
© 2004 American Heart Association, Inc.
Original Contributions |
T Polymorphism in the F12 Gene Is a Risk Factor for Ischemic Stroke in the Spanish Population
From the Hemostasia Unit (A.S., J.M., I.T., A.O., R.F., J.M.S., J.C.S., J.F.), Department of Hematology, and the Stroke Unit (R.B., J.M.-F.), Department of Neurology, Universitat Autónoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Correspondence to Dr Amparo Santamaría Ortiz, Department of Hematology, Hospital de la Santa Creu i Sant Pau, C/ Sant Antoni M
Claret, 167, 08025, Barcelona, Spain. E-mail msantamaria{at}hsp.santpau.es
Background and Purpose Ischemic stroke (IS) is a complex disease that involves genetic and environmental factors. In a family-based study (the Genetic Analysis of Idiopathic Thrombophilia [GAIT] Project) that included a genome-wide scan, we demonstrated that a common polymorphism (46 C
T) in the exon 1 of the F12 gene jointly influences variability of plasma Factor XII levels and susceptibility to thrombotic disease. We have investigated the risk of IS related to this polymorphism in a casecontrol study.
Methods We studied 436 individuals: 205 diagnosed with IS and 231 agegenderethnic control subjects. We measured Factor VIIIc, fibrinogen, and Factor XIIc levels, and we genotyped the 46 C
T polymorphism in the F12 gene.
Results There were 91 women and 114 men in the IS group and 109 women and 122 men in the control group. We confirmed our previous observation that individuals with different genotypes for the 46 C
T polymorphism showed significant differences in Factor XIIc levels. Most importantly, the mutated T allele in the homozygous state (genotype T/T) was associated with an increased risk of IS with an adjusted odds ratio of 4.1 (95% CI, 1.1 to 15.9).
Conclusions This study suggests that the 46 C
T polymorphism is a genetic risk factor for IS in the Spanish population. In addition, our results confirm that the use of genetic linkage studies along with a casecontrol association study is an extremely valuable approach for identifying DNA variants that affect complex diseases.
Key Words: Factor XII polymorphism stroke, ischemic
This article has been cited by other articles:
![]() |
K. H. Reuner, E. Jenetzky, A. Aleu, F. Litfin, P. Mellado, M. Kloss, E. Juttler, A. J. Grau, H. Rickmann, H. Patscheke, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis Neurology, January 8, 2008; 70(2): 129 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gailani and T. Renne Intrinsic Pathway of Coagulation and Arterial Thrombosis Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2507 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Renne, M. Pozgajova, S. Gruner, K. Schuh, H.-U. Pauer, P. Burfeind, D. Gailani, and B. Nieswandt Defective thrombus formation in mice lacking coagulation factor XII J. Exp. Med., July 18, 2005; 202(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |